Literature DB >> 16395097

Serogroup 19 pneumococci containing both mef and erm macrolide resistance determinants in an American city.

Philip Toltzis1, Michael Dul, Mary Ann O'Riordan, Michael R Jacobs, Jeffrey Blumer.   

Abstract

BACKGROUND: Asia has experienced a striking incidence of infection by highly resistant pneumococi containing both principal macrolide resistance determinants, namely, the mef efflux pump and the erm ribosomal methylase. mef/erm-containing pneumococci have not been identified in significant numbers in North America.
METHODS: Pneumococci were isolated as part of a larger study in Cleveland, OH examining colonization patterns among children randomized to 1 of 4 outpatient antibiotics for acute otitis media. Azithromycin-resistant organisms were tested for the presence of mef and erm sequences by polymerase chain reaction. The clonal relationship of pneumococci containing both genes was determined by pulsed field gel electrophoresis and multilocus sequence testing. Selected characteristics of children harboring mef/erm-containing organisms were compared with other participants of the larger study.
RESULTS: Of 221 children colonized by pneumococci, 17 (7.7%) were colonized with an organism containing both determinants. All mef/erm-positive organisms demonstrated azithromycin minimum inhibitory concentrations > or =256 microg/mL and were coresistant to all other agents tested. The mef/erm-containing organisms were serotype 19A and 19F, all but 1 of which manifested similar pulsed field gel electrophoresis patterns. Multilocus sequence testing analysis indicated a relationship to the Taiwan-14 macrolide-resistant strain that has spread throughout Eastern Asia. More than one-third of children colonized by a mef/erm-containing organism had received > or =1 dose of conjugate pneumococcal vaccine, a significantly higher proportion than children carrying less resistant organisms (P< 0.01). No other characteristics distinguished children harboring a mef/erm-containing pneumococcus from other children enrolled in the larger study.
CONCLUSION: Clonally related mef/erm-containing serogroup 19 pneumococci were prominent among otherwise healthy children in a North American metropolitan area. Our findings suggest that spread of these organisms may be poorly contained by immunization.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16395097     DOI: 10.1097/01.inf.0000195784.27503.f0

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  4 in total

1.  Prevalence of serotype 19A Streptococcus pneumoniae among isolates from U.S. children in 2005-2006 and activity of faropenem.

Authors:  Ian A Critchley; Michael R Jacobs; Steven D Brown; Maria M Traczewski; Glenn S Tillotson; Nebojsa Janjic
Journal:  Antimicrob Agents Chemother       Date:  2008-04-28       Impact factor: 5.191

2.  Dominance of multidrug resistant CC271 clones in macrolide-resistant streptococcus pneumoniae in Arizona.

Authors:  Jolene R Bowers; Elizabeth M Driebe; Jennifer L Nibecker; Bette R Wojack; Derek S Sarovich; Ada H Wong; Pius M Brzoska; Nathaniel Hubert; Andrew Knadler; Lindsey M Watson; David M Wagner; Manohar R Furtado; Michael Saubolle; David M Engelthaler; Paul S Keim
Journal:  BMC Microbiol       Date:  2012-01-18       Impact factor: 3.605

3.  Serotype distribution and antimicrobial resistance of Streptococcus pneumoniae isolates causing invasive diseases from Shenzhen Children's Hospital.

Authors:  Xiang Ma; Ruizhen Zhao; Zhuoya Ma; Kaihu Yao; Sangjie Yu; Yuejie Zheng; Yonghong Yang
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

4.  Streptococcus pneumoniae serotype 19A in children, South Korea.

Authors:  Eun Hwa Choi; So Hee Kim; Byung Wook Eun; Sun Jung Kim; Nam Hee Kim; Jina Lee; Hoan Jong Lee
Journal:  Emerg Infect Dis       Date:  2008-02       Impact factor: 6.883

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.